~~<i id='8F22B085A3'><strike id='8F22B085A3'><tt id='8F22B085A3'><pre id='8F22B085A3'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

hotspot

author：entertainment 2025-08-27 22:29:29 - browse：71

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： First Opinion Podcast: Long Covid needs a new approach

hotspot

Wikipedia

knowledge

hotspot

entertainment

hotspot

AhearttransplantoperationattheClevelandClinic.AndreaYanak/APAnewmethodofhearttransplantationthatuses

WSS

Solve the antibiotic resistance crisis with preventive drugs

STAT Readout Newsletter: Today's biggest biotech updates

Medicare reduced heart disease by changing how it pays doctors

STAT Summit: How a Chicago ER doctor tackles gun violence

CEOs share strategies for surviving biotech slump

Biogen nominates mother of director’s child to replace him on board

entertainment

hotspot

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

Beam Therapeutics to lay off 20% of its staff, re

Hollywood unions extend contract negotiations for actors

Solve the antibiotic resistance crisis with preventive drugs

Hepatitis C has a cure — but many Americans still lack access to it

Living organ donors deserve priority status for transplants

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Beam Therapeutics to lay off 20% of its staff, re

Medicare proposal to cover medical devices draws a mixed reaction

FDA warns J&J's Abiomed: We will regulate your software

Wikipedia

The thinking behind the controversial eating disorder chatbot Tessa

CEOs share strategies for surviving biotech slump

Mom launches Girl Scout troop for LGBTQ youth in Texas

Why health workers in Gaza are injured or die at high rates

Medicare reduced heart disease by changing how it pays doctors

Impact of Dobbs ruling felt at reproductive medicine meeting

knowledge

hotspot

entertainment

hotspot